Literature DB >> 26348625

α-Methyl Acyl CoA Racemase Provides Mycobacterium tuberculosis Catabolic Access to Cholesterol Esters.

Rui Lu1, Werner Schmitz2, Nicole S Sampson1.   

Abstract

Metabolism of cholesterol by Mycobacterium tuberculosis (Mtb) contributes to its pathogenesis. We show that ChsE4-ChsE5 (Rv3504/Rv3505) specifically catalyzes dehydrogenation of the (25S)-3-oxo-cholest-4-en-26-oyl-CoA diastereomer in cholesterol side chain β-oxidation. Thus, a dichotomy between the supply of both 25R and 25S metabolic precursors by upstream cytochrome P450s and the substrate stereospecificity of ChsE4-ChsE5 exists. We reconcile the dilemma of 25R metabolite production by demonstrating that mycobacterial MCR (Rv1143) can efficiently epimerize C25 diastereomers of 3-oxo-cholest-4-en-26-oyl-CoA. Our data suggest that cholesterol and cholesterol ester precursors can converge into a single catabolic pathway, thus widening the metabolic niche in which Mtb survives.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26348625      PMCID: PMC4600597          DOI: 10.1021/acs.biochem.5b00911

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  29 in total

1.  Crystallization and preliminary X-ray diffraction studies of an alpha-methylacyl-CoA racemase from Mycobacterium tuberculosis.

Authors:  Prasenjit Bhaumik; Petri Kursula; Ville Ratas; Ernst Conzelmann; J Kalervo Hiltunen; Werner Schmitz; Rik K Wierenga
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2003-01-23

2.  Pathway profiling in Mycobacterium tuberculosis: elucidation of cholesterol-derived catabolite and enzymes that catalyze its metabolism.

Authors:  Suzanne T Thomas; Brian C VanderVen; David R Sherman; David G Russell; Nicole S Sampson
Journal:  J Biol Chem       Date:  2011-11-01       Impact factor: 5.157

Review 3.  The Mycobacterium tuberculosis cytochrome P450 system.

Authors:  Hugues Ouellet; Jonathan B Johnston; Paul R Ortiz de Montellano
Journal:  Arch Biochem Biophys       Date:  2009-07-25       Impact factor: 4.013

4.  FadA5 a thiolase from Mycobacterium tuberculosis: a steroid-binding pocket reveals the potential for drug development against tuberculosis.

Authors:  Christin M Schaefer; Rui Lu; Natasha M Nesbitt; Johannes Schiebel; Nicole S Sampson; Caroline Kisker
Journal:  Structure       Date:  2014-12-04       Impact factor: 5.006

5.  Genetic requirements for mycobacterial survival during infection.

Authors:  Christopher M Sassetti; Eric J Rubin
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-20       Impact factor: 11.205

6.  Cholesterol ester oxidation by mycobacterial cytochrome P450.

Authors:  Daniel J Frank; Yarrow Madrona; Paul R Ortiz de Montellano
Journal:  J Biol Chem       Date:  2014-09-10       Impact factor: 5.157

7.  Mycobacterium tuberculosis utilizes a unique heterotetrameric structure for dehydrogenation of the cholesterol side chain.

Authors:  Suzanne T Thomas; Nicole S Sampson
Journal:  Biochemistry       Date:  2013-04-18       Impact factor: 3.162

8.  Identification of ligands for DAF-12 that govern dauer formation and reproduction in C. elegans.

Authors:  Daniel L Motola; Carolyn L Cummins; Veerle Rottiers; Kamalesh K Sharma; Tingting Li; Yong Li; Kelly Suino-Powell; H Eric Xu; Richard J Auchus; Adam Antebi; David J Mangelsdorf
Journal:  Cell       Date:  2006-03-09       Impact factor: 41.582

9.  Rv1106c from Mycobacterium tuberculosis is a 3beta-hydroxysteroid dehydrogenase.

Authors:  Xinxin Yang; Eugenie Dubnau; Issar Smith; Nicole S Sampson
Journal:  Biochemistry       Date:  2007-07-14       Impact factor: 3.162

10.  Cholesterol utilization in mycobacteria is controlled by two TetR-type transcriptional regulators: kstR and kstR2.

Authors:  Sharon L Kendall; Philippa Burgess; Ricardo Balhana; Mike Withers; Annemieke Ten Bokum; J Shaun Lott; Chen Gao; Iria Uhia-Castro; Neil G Stoker
Journal:  Microbiology (Reading)       Date:  2010-02-18       Impact factor: 2.777

View more
  4 in total

Review 1.  Cholesterol and fatty acids grease the wheels of Mycobacterium tuberculosis pathogenesis.

Authors:  Kaley M Wilburn; Rachael A Fieweger; Brian C VanderVen
Journal:  Pathog Dis       Date:  2018-03-01       Impact factor: 3.166

Review 2.  Cholesterol metabolism: a potential therapeutic target in Mycobacteria.

Authors:  Areej Abuhammad
Journal:  Br J Pharmacol       Date:  2017-01-24       Impact factor: 8.739

3.  Post-translational Succinylation of Mycobacterium tuberculosis Enoyl-CoA Hydratase EchA19 Slows Catalytic Hydration of Cholesterol Catabolite 3-Oxo-chol-4,22-diene-24-oyl-CoA.

Authors:  Amber C Bonds; Tianao Yuan; Joshua M Werman; Jungwon Jang; Rui Lu; Natasha M Nesbitt; Miguel Garcia-Diaz; Nicole S Sampson
Journal:  ACS Infect Dis       Date:  2020-07-27       Impact factor: 5.084

4.  Identification of potential lipid biomarkers for active pulmonary tuberculosis using ultra-high-performance liquid chromatography-tandem mass spectrometry.

Authors:  Yu-Shuai Han; Jia-Xi Chen; Zhi-Bin Li; Jing Chen; Wen-Jing Yi; Huai Huang; Li-Liang Wei; Ting-Ting Jiang; Ji-Cheng Li
Journal:  Exp Biol Med (Maywood)       Date:  2020-11-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.